High-throughput lectin magnetic bead array-coupled tandem mass spectrometry for glycoprotein biomarker discovery
Alterations in protein glycosylation occur during development and progression of many diseases, hence glycomics and glycoproteomics have emerged as important tools in glycobiomarker discovery. High‐throughput glycan profiling can now be achieved with the recent developments in MS‐based techniques. T...
Saved in:
Published in: | Electrophoresis Vol. 32; no. 24; pp. 3564 - 3575 |
---|---|
Main Authors: | , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Weinheim
WILEY-VCH Verlag
01-12-2011
WILEY‐VCH Verlag |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Alterations in protein glycosylation occur during development and progression of many diseases, hence glycomics and glycoproteomics have emerged as important tools in glycobiomarker discovery. High‐throughput glycan profiling can now be achieved with the recent developments in MS‐based techniques. To enable identification and rapid monitoring of glycosylation changes in serum proteins, we developed a semi‐automated high‐throughput glycoprotein biomarker discovery platform termed lectin magnetic bead array‐coupled tandem mass spectrometry (LeMBA‐MS) which includes (i) effective single‐step serum glycoprotein isolation using a panel of 20 individual lectin‐coated magnetic beads in microplate format, (ii) on‐bead trypsin digestion, and (iii) nanoLC‐MS/MS with lectin exclusion list. With use of appropriate sequence databases, LeMBA‐MS can detect glycosylation changes regardless of the species. By spiking known amounts of titrated ovalbumin to a serum sample, we report nanomolar sensitivity, and linearity of response of LeMBA‐MS using concanavalin A‐coupled beads. Neuraminidase treatment led to reduction of binding to sialic acid‐binding lectins. Interestingly, we found that desialylation caused increased binding of haptoglobin and hemopexin to mannose‐specific lectins, pointing to the importance of identifying a signature of lectin‐binding. High‐throughput LeMBA‐MS to generate glycosylation signatures will facilitate glycobiomarker discovery. LeMBA can be coupled to down‐stream detection platforms for validation, making it a truly versatile platform. |
---|---|
Bibliography: | ArticleID:ELPS201100341 University of Queensland International Research Tuition Awards University of Queensland Research Scholarship CIHR - No. MOP-62975 ark:/67375/WNG-HX4GKK72-9 istex:6E79175813D1093383E537A355E7583755905F32 ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 |
ISSN: | 0173-0835 1862-8346 1522-2683 |
DOI: | 10.1002/elps.201100341 |